Skip to main content
Clinical Trials/NCT04172285
NCT04172285
Unknown
Not Applicable

Effects of an Home-base Physical Activity Program for Counteracting Sarcopenia in Elderly: a Randomized-controlled Trial.

I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio1 site in 1 country16 target enrollmentSeptember 18, 2019
ConditionsSarcopenia

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Sarcopenia
Sponsor
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Enrollment
16
Locations
1
Primary Endpoint
Lower limb strength
Last Updated
5 years ago

Overview

Brief Summary

Sarcopenia is a pathophysiological process associated with aging and some metabolic conditions characterized by progressive muscle tissue loss, which may lead to loss of strangth and performance and increase risk of falls and fractures, physical disability and premature death. Therefore, it is necessary to identify personalized programs of physical activity and supplementation for elderly population in order to improve their physical functions, muscle strengh and body composition.

With the present project we aime to assess the effect of a feasible home-based exercise program coupled with food supplementation to improve muscle strength, muscle volume and muscle physical performance potentially associated with sarcopenia in elderly people.

Registry
clinicaltrials.gov
Start Date
September 18, 2019
End Date
December 20, 2021
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Sedentary lifestyle.
  • Cognitively intact.
  • Autonomous walking.
  • Acceptance of informed consent.

Exclusion Criteria

  • Body mass index lower than 18.5 and uppen than 40 kg/m
  • History of cancer.
  • Pacemaker user.
  • History of epileptic episodes.
  • Endocrine-metabolic, neurological, muscular and ortopedic pathologies that affect movement functions.
  • Bone fractures that influence movement functions.
  • Surgical treatments in the prior 6 months.
  • Use of antieptilectics, glucocorticoids, rhGH and testosterone.
  • Hepatic and muscular pathologies

Outcomes

Primary Outcomes

Lower limb strength

Time Frame: Baseline and Week 24

Assessed by chair stand test

Secondary Outcomes

  • Body composition(Baseline and Week 24)
  • Quantify thigh cross sectional area(Baseline and Week 24)
  • Maximum isometric force that a hand can squeeze(Baseline and Week 24)
  • Maximal Isometric Strength of Knee flexors and extensors(Baseline AND Week 24)
  • Dynamic balance and gait deficits(Baseline and Week 24)

Study Sites (1)

Loading locations...

Similar Trials